Trials / Completed
CompletedNCT01048541
Bladder Scan of Residual Urine With New Catheter
A Non-Inferiority Bladder Scan Study to Investigate Residual Urine After Use of Intermittent Catheters in Male Subjects
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Coloplast A/S · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Male intermittent catheters (ICs) range from 340-500 mm long, with the European standard minimum length being 360 mm for a catheter without a balloon and 275 mm for one with a balloon. This length is defined by hospital standards although it is known that the male urethra has an approximate maximum length of 29 cmA new intermittent catheter developed by Coloplast A/S is a 30-cm-long sterile, ready-to-use, hydrophilic-coated male catheter. There is a lack of clinical data documenting that male ICs that are shorter and more or less flexible than standard catheters can sufficiently empty the bladder of male subjects. This will be tested using ultrasound to measure residual urine in the bladder following catheterisation with new product and standard length catheter.
Detailed description
See brief summary
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Test Catheter - SpeediCath Compact Male | Compact catheter for intermittent catheterisation |
| DEVICE | SpeediCath | Catheter for intermittent catheterisation |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2010-01-13
- Last updated
- 2012-09-03
- Results posted
- 2012-09-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01048541. Inclusion in this directory is not an endorsement.